Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Swiss Childhood Health and Nutrition Survey (CHildHNS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03309189
Recruitment Status : Completed
First Posted : October 13, 2017
Last Update Posted : July 13, 2018
Sponsor:
Information provided by (Responsible Party):
Isabelle Herter-Aeberli, Swiss Federal Institute of Technology

Brief Summary:
The aim of the present study is to assess the prevalence of overweight and obesity in 6 to 12 year old children in Switzerland. This data will be used to investigate trends in the development of overweight and obesity in Switzerland. In addition, a questionnaire will be used to assess data on physical activity, nutrition, health and socioeconomic background and waist circumference as well as skin fold thicknesses will be measured.

Condition or disease
Overweight and Obesity in Schoolchildren

Layout table for study information
Study Type : Observational
Actual Enrollment : 2292 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: National Studie Gesundheit Und Ernährung Von Primarschülern
Actual Study Start Date : August 17, 2017
Actual Primary Completion Date : March 31, 2018
Actual Study Completion Date : June 30, 2018



Primary Outcome Measures :
  1. Prevalence of overweight and obesity [ Time Frame: 1 day of first visit ]
    Based on weight and height measurements BMI z-scores will be calculated for the classification in the different weight status groups (underweight, normal weight, overweight, obese)


Secondary Outcome Measures :
  1. Waist circumference [ Time Frame: 1 day of first visit ]
  2. body fat % [ Time Frame: 1 day of first visit ]
    Based on the measurement of skinfold thicknesses at 4 sites body fat % will be calculated

  3. Physical activity [ Time Frame: 1 day of first visit ]
    Assessed using a questionnaire

  4. Nutrition [ Time Frame: 1 day of first visit ]
    Assessed using a questionnaire

  5. General health [ Time Frame: 1 day of first visit ]
    Assessed using a questionnaire

  6. Socioeconomic background [ Time Frame: 1 day of first visit ]
    Assessed using a questionnaire


Other Outcome Measures:
  1. Age [ Time Frame: 1 day of first visit ]
    Assessed using a questionnaire

  2. Gender [ Time Frame: 1 day of first visit ]
    Assessed using a questionnaire



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   6 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
All children at the selected schools and in the defined age range are eligible.
Criteria

Inclusion Criteria:

  • age between 6 and 12 years

Exclusion Criteria:

  • none

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03309189


Locations
Layout table for location information
Switzerland
ETH Zurich
Zürich, Switzerland, 8092
Sponsors and Collaborators
Isabelle Herter-Aeberli
Investigators
Layout table for investigator information
Principal Investigator: Isabelle Herter, PhD ETH Zurich
Layout table for additonal information
Responsible Party: Isabelle Herter-Aeberli, Senior Scientist, Swiss Federal Institute of Technology
ClinicalTrials.gov Identifier: NCT03309189    
Other Study ID Numbers: CHildHNS
First Posted: October 13, 2017    Key Record Dates
Last Update Posted: July 13, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Overweight
Body Weight
Signs and Symptoms